First Tracks Biotherapeutics, Inc. - Ordinary Shares (TRAX)
NASDAQ · Healthcare
$36.87+0.96%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.13B
- P/E ratio
- —
- EPS
- —
- Volume
- 745,474
- 52-week high
- —
- 52-week low
- —
- Open
- $36.48
- Day high
- $39.27
- Day low
- $36.00
Financial highlights
Annual financials for First Tracks Biotherapeutics, Inc. - Ordinary Shares are being compiled and will appear here soon.
About First Tracks Biotherapeutics, Inc. - Ordinary Shares
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
- CEO
- Daniel R. Faga
- Employees
- 104
- Country
- US
- IPO date
- Apr 20, 2026
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is First Tracks Biotherapeutics, Inc. - Ordinary Shares's stock price today?
- TRAX is trading at $36.87 as of Jul 20, 2026.
- What is First Tracks Biotherapeutics, Inc. - Ordinary Shares's market cap?
- First Tracks Biotherapeutics, Inc. - Ordinary Shares (TRAX) has a market capitalization of $1.13B.
- What sector is First Tracks Biotherapeutics, Inc. - Ordinary Shares in?
- First Tracks Biotherapeutics, Inc. - Ordinary Shares operates in the Healthcare sector.